Larsen CG - Search Results

1

Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophils in vitro.

Fogh K, Larsen CG, Iversen L, Kragballe K. Fogh K, et al. Among authors: larsen cg. Agents Actions. 1992 Mar;35(3-4):227-31. doi: 10.1007/BF01997504. Agents Actions. 1992. PMID: 1529797 Free article.

2

1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression.

Riis JL, Johansen C, Gesser B, Møller K, Larsen CG, Kragballe K, Iversen L. Riis JL, et al. Among authors: larsen cg. Arch Dermatol Res. 2004 Oct;296(5):195-202. doi: 10.1007/s00403-004-0509-9. Epub 2004 Sep 15. Arch Dermatol Res. 2004. PMID: 15372276

3

1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production.

Larsen CG, Kristensen M, Paludan K, Deleuran B, Thomsen MK, Zachariae C, Kragballe K, Matsushima K, Thestrup-Pedersen K. Larsen CG, et al. Biochem Biophys Res Commun. 1991 May 15;176(3):1020-6. doi: 10.1016/0006-291x(91)90384-j. Biochem Biophys Res Commun. 1991. PMID: 2039486

4

Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.

Larsen FG, Jakobsen P, Larsen CG, Nørgaard A, Kragballe K, Nielsen-Kudsk F. Larsen FG, et al. Among authors: larsen cg. Pharmacol Toxicol. 1987 Aug;61(2):85-8. doi: 10.1111/j.1600-0773.1987.tb01780.x. Pharmacol Toxicol. 1987. PMID: 2959917 Clinical Trial.

5

Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.

Larsen FG, Jakobsen P, Larsen CG, Kragballe K, Nielsen-Kudsk F. Larsen FG, et al. Among authors: larsen cg. Pharmacol Toxicol. 1988 Mar;62(3):159-65. doi: 10.1111/j.1600-0773.1988.tb01865.x. Pharmacol Toxicol. 1988. PMID: 2967472

6

The effect of second-line antirheumatic drugs on interleukin-8 mRNA synthesis and protein secretion in human endothelial cells.

Deleuran B, Kristensen M, Paludan K, Zachariae C, Larsen CG, Zachariae E, Thestrup-Pedersen K. Deleuran B, et al. Among authors: larsen cg. Cytokine. 1992 Sep;4(5):403-9. doi: 10.1016/1043-4666(92)90085-6. Cytokine. 1992. PMID: 1358240

7

Regulation of human T lymphocyte chemotaxis in vitro by T cell-derived cytokines IL-2, IFN-gamma, IL-4, IL-10, and IL-13.

Tan J, Deleuran B, Gesser B, Maare H, Deleuran M, Larsen CG, Thestrup-Pedersen K. Tan J, et al. Among authors: larsen cg. J Immunol. 1995 Apr 15;154(8):3742-52. J Immunol. 1995. PMID: 7535813

8

Interleukin-8 induces its own production in CD4+ T lymphocytes: a process regulated by interleukin 10.

Gesser B, Deleuran B, Lund M, Vestergård C, Lohse N, Deleuran M, Jensen SL, Pedersen SS, Thestrup-Pedersen K, Larsen CG. Gesser B, et al. Among authors: larsen cg. Biochem Biophys Res Commun. 1995 May 25;210(3):660-9. doi: 10.1006/bbrc.1995.1711. Biochem Biophys Res Commun. 1995. PMID: 7763239

9

Identification of functional domains on human interleukin 10.

Gesser B, Leffers H, Jinquan T, Vestergaard C, Kirstein N, Sindet-Pedersen S, Jensen SL, Thestrup-Pedersen K, Larsen CG. Gesser B, et al. Among authors: larsen cg. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14620-5. doi: 10.1073/pnas.94.26.14620. Proc Natl Acad Sci U S A. 1997. PMID: 9405662 Free PMC article.

10

ETH615, a synthetic inhibitor of leukotriene biosynthesis and function, also inhibits the production of and biological responses towards interleukin-8.

Kristensen M, Jinquan T, Thomsen MK, Zachariae C, Paludan K, Ahnfelt-Rønne I, Matsushima K, Thestrup-Pedersen K, Larsen CG. Kristensen M, et al. Among authors: larsen cg. Exp Dermatol. 1993 Aug;2(4):165-70. doi: 10.1111/j.1600-0625.1993.tb00027.x. Exp Dermatol. 1993. PMID: 8162335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters